Dexmedetomidine enhances Mitophagy via PINK1 to alleviate hippocampal neuronal Pyroptosis and improve postoperative cognitive dysfunction in elderly rat

Postoperative cognitive dysfunction (POCD) is a common complication in elderly surgical patients, significantly affecting their quality of life. Dexmedetomidine (Dex), an anesthetic, has shown promise in alleviating POCD, but its underlying mechanism remains unclear. This study aims to explore how Dex improves POCD in aged rats by targeting the PINK1-mediated mitochondrial Autophagy pathway, reducing Caspase-1/11-GSDMD-induced hippocampal neuronal Pyroptosis. Transcriptome Sequencing identified 300 differentially expressed genes enriched in the mitochondrial Autophagy pathway in Dex-treated POCD rat hippocampal tissue, with Pink1 as a key candidate. In a POCD rat model, Dex treatment upregulated hippocampal PINK1 expression. In vitro experiments using H19-7 rat hippocampal neurons revealed that Dex enhanced mitochondrial Autophagy and suppressed neuronal Pyroptosis by upregulating PINK1. Further mechanistic validation demonstrated that Dex activated PINK1-mediated mitochondrial Autophagy, inhibiting Caspase-1/11-GSDMD-induced neuronal Pyroptosis. In vivo experiments confirmed Dex's ability to reduce Caspase-1/11-GSDMD-dependent hippocampal neuronal Pyroptosis and improve postoperative cognitive function in aged rats. Dexmedetomidine improves postoperative cognitive dysfunction in elderly rats by enhancing mitochondrial Autophagy via PINK1 upregulation, mitigating Caspase-1/11-GSDMD-induced neuronal Pyroptosis.

Caspase-1/11-GSDMD; Dexmedetomidine; Mitochondrial autophagy; PINK1; Postoperative cognitive dysfunction.